KR20140022900A - 2종의 상이한 점도 증강제를 포함하는 점도 증강 시스템을 갖는 안과 조성물 - Google Patents

2종의 상이한 점도 증강제를 포함하는 점도 증강 시스템을 갖는 안과 조성물 Download PDF

Info

Publication number
KR20140022900A
KR20140022900A KR1020137030487A KR20137030487A KR20140022900A KR 20140022900 A KR20140022900 A KR 20140022900A KR 1020137030487 A KR1020137030487 A KR 1020137030487A KR 20137030487 A KR20137030487 A KR 20137030487A KR 20140022900 A KR20140022900 A KR 20140022900A
Authority
KR
South Korea
Prior art keywords
viscosity
composition
eye
consumable
ophthalmic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020137030487A
Other languages
English (en)
Korean (ko)
Inventor
마수드 에이. 쵸환
말레이 고쉬
Original Assignee
알콘 리서치, 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 알콘 리서치, 리미티드 filed Critical 알콘 리서치, 리미티드
Publication of KR20140022900A publication Critical patent/KR20140022900A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020137030487A 2011-04-22 2012-04-19 2종의 상이한 점도 증강제를 포함하는 점도 증강 시스템을 갖는 안과 조성물 Ceased KR20140022900A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161478081P 2011-04-22 2011-04-22
US61/478,081 2011-04-22
PCT/US2012/034171 WO2012145460A2 (en) 2011-04-22 2012-04-19 Ophthalmic composition with a viscosity enhancement system having two different viscosity enhancing agents

Publications (1)

Publication Number Publication Date
KR20140022900A true KR20140022900A (ko) 2014-02-25

Family

ID=46025951

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020137030487A Ceased KR20140022900A (ko) 2011-04-22 2012-04-19 2종의 상이한 점도 증강제를 포함하는 점도 증강 시스템을 갖는 안과 조성물

Country Status (10)

Country Link
US (1) US20120269862A1 (cg-RX-API-DMAC7.html)
EP (1) EP2699228A2 (cg-RX-API-DMAC7.html)
JP (2) JP2014525891A (cg-RX-API-DMAC7.html)
KR (1) KR20140022900A (cg-RX-API-DMAC7.html)
CN (1) CN104039307A (cg-RX-API-DMAC7.html)
AU (1) AU2012245538B2 (cg-RX-API-DMAC7.html)
CA (1) CA2833591A1 (cg-RX-API-DMAC7.html)
MX (1) MX2013012307A (cg-RX-API-DMAC7.html)
RU (1) RU2013152013A (cg-RX-API-DMAC7.html)
WO (1) WO2012145460A2 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10174006B2 (en) * 2013-06-06 2019-01-08 Novartis Ag Topical aqueous ophthalmic compositions containing a 1H-indole-1-carboxamide derivative and use thereof for treatment of ophthalmic disease
RU2595837C2 (ru) * 2014-09-29 2016-08-27 Открытое Акционерное Общество "Татхимфармпрепараты" Состав и способ получения глазных капель
CN113366025A (zh) 2019-01-30 2021-09-07 鲍希与洛姆伯股份有限公司 交联的聚合物网络及其用途

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4027020A (en) 1974-10-29 1977-05-31 Millmaster Onyx Corporation Randomly terminated capped polymers
US3931319A (en) 1974-10-29 1976-01-06 Millmaster Onyx Corporation Capped polymers
US4407791A (en) 1981-09-28 1983-10-04 Alcon Laboratories, Inc. Ophthalmic solutions
US4525346A (en) 1981-09-28 1985-06-25 Alcon Laboratories, Inc. Aqueous antimicrobial ophthalmic solutions
US4836986A (en) 1984-09-28 1989-06-06 Bausch & Lomb Incorporated Disinfecting and preserving systems and methods of use
US5037647A (en) 1988-09-15 1991-08-06 Alcon Laboratories, Inc. Aqueous antimicrobial opthalmic solutions comprised of quaternary ammonium compound, citric acid, citrate and sodium chloride
US5145643A (en) 1990-01-05 1992-09-08 Allergan, Inc. Nonoxidative ophthalmic compositions and methods for preserving and using same
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
US5300287A (en) 1992-11-04 1994-04-05 Alcon Laboratories, Inc. Polymeric antimicrobials and their use in pharmaceutical compositions
DE69818675T2 (de) 1997-07-29 2004-07-29 Alcon Laboratories, Inc., Fort Worth Galaktomannanpolymere und borat enthaltende augenarzneimittel
US6174524B1 (en) * 1999-03-26 2001-01-16 Alcon Laboratories, Inc. Gelling ophthalmic compositions containing xanthan gum
JP5000835B2 (ja) * 2000-08-25 2012-08-15 千寿製薬株式会社 水性懸濁液剤
AR031135A1 (es) * 2000-10-10 2003-09-10 Upjohn Co Composiciones de antibiotico topico para el tratamiento de infecciones oculares
CA2839849C (en) * 2003-06-13 2017-03-07 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
JP4850513B2 (ja) * 2003-07-03 2012-01-11 株式会社メニコン 点眼用組成物
JP4963359B2 (ja) * 2005-01-12 2012-06-27 ロート製薬株式会社 眼局所適用製剤
CN101057966B (zh) * 2007-05-16 2011-04-13 中国科学院上海药物研究所 一种表皮生长因子眼用脂质纳米载体原位凝胶制剂
CN101073556A (zh) * 2007-06-25 2007-11-21 苏州瑞桥医药科技有限公司 一种散瞳眼用制剂及其制备方法
AU2009225931B9 (en) 2008-03-17 2014-04-03 Novartis Ag Aqueous pharmaceutical compositions containing borate-polyol complexes
CN101564374A (zh) * 2008-04-25 2009-10-28 北京和润创新医药科技发展有限公司 一种药物眼用即型凝胶
JP5731980B2 (ja) * 2008-10-09 2015-06-10 ラムズコア, インコーポレイテッド ドライアイ症候群の処置のための組成物および方法
US8501800B2 (en) * 2009-03-05 2013-08-06 Insite Vision Incorporated Controlled-release ophthalmic vehicles
TWI489997B (zh) 2009-06-19 2015-07-01 Alcon Res Ltd 含有硼酸-多元醇錯合物之水性藥學組成物

Also Published As

Publication number Publication date
RU2013152013A (ru) 2015-05-27
AU2012245538B2 (en) 2017-06-15
EP2699228A2 (en) 2014-02-26
CN104039307A (zh) 2014-09-10
MX2013012307A (es) 2014-01-31
AU2012245538A1 (en) 2013-10-17
CA2833591A1 (en) 2012-10-26
WO2012145460A3 (en) 2014-07-24
WO2012145460A2 (en) 2012-10-26
JP2014525891A (ja) 2014-10-02
JP2017088629A (ja) 2017-05-25
US20120269862A1 (en) 2012-10-25

Similar Documents

Publication Publication Date Title
JP5661640B2 (ja) 薬学的懸濁物
KR101689924B1 (ko) 고농도 올로파타딘 안과용 조성물
JP2012511009A5 (cg-RX-API-DMAC7.html)
JP6538920B2 (ja) 水性液剤
KR20130100273A (ko) 점안용 수성 조성물
JP2005187407A (ja) アレルギー眼疾患用眼科組成物
KR20140022901A (ko) 2종의 상이한 점도 증강제를 포함하는 점도 증강 시스템을 갖는 안과 조성물
AU2012245538B2 (en) Ophthalmic composition with a viscosity enhancement system having two different viscosity enhancing agents
US12576126B2 (en) Nanoemulsion ophthalmic composition comprising cyclosporine and menthol, and preparation method thereof
JP5420877B2 (ja) 眼科用剤
JP6730500B2 (ja) 水性液剤
WO2019123266A1 (en) Ophthalmic composition having a prostaglandin and a beta-blocker
HK1210589B (en) Aqueous liquid medicine

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20131118

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20170418

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20180412

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20180906

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20180412

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I